BNOX (Bionomics Ltd.) Net earnings per share (EPS TTM)

Bionomics Ltd (BNOX) - corporate logo

Bionomics Limited is developing a neurobiological ecosystem, combining ion channel modulation patent platforms with clinical trials of innovative PTSD treatments. The annual EPS growth rate over the last 12 months demonstrates financial dynamics where -22.60 represents the current metric. Such developments open the market for safe psychopharmacology, creating drugs for anxiety disorders without the risk of addiction or sedation.

Bionomics Ltd - BNOX Earnings per share for the last twelve months (period 02/11/2024 - 02/20/2024)

BNOX (Bionomics Ltd): analytical breakdowns and indicator data

- price and consensus price forecast:
Fundamental company valuation:BNOX Bionomics Limited
Flagship merchandise of Bionomics Ltd.

This indicator measures the rate of change in net earnings per share over the last twelve months relative to the previous year. Analyzing the current annual EPS TTM growth rate allows for an assessment of business scaling efficiency against industry benchmarks. The metric is calculated as the percentage deviation of earnings adjusted for one-time items. For Bionomics Limited (BNOX), the trend of this indicator reflects the balance between neurobiologist costs and drug development performance. Retaining scientists through stock option programs directly impacts final profitability.

Direct competitors

Net earnings per one share for the last twelve months Jazz Pharma|CYTK (Cytokinetics Inc.) - Net earnings per share for the last 12 months|PTC Bio (PTCT) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Scholar Rock|CNTA: Earnings per share for the trailing year|Earnings per share for the last twelve months Dyne Therapeutics (DYN)|EWTX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Rapport Pharma RAPP|Alumis Pharma - Earnings per share for the last twelve months|ZVRA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Contineum Therapeutics, Inc.|LRMR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Capricor Therapeutics CAPR|Net earnings per share for the last 12 months TRDA|Net earnings per one share for the last twelve months Channel PTHS|Earnings per share for the last twelve months MediciNova Inc. (MNOV)|SER - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BTAI (BioXcel Therapeutics Inc)|ProMIS Neurosciences (PMN) - Net earnings per one share for the last twelve months|Apimeds Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AEON Biopharma, Inc.|NLSP (NLS Pharma) - Net earnings per share for the last 12 months|fsdpharma.com - Earnings per share for the trailing year|RETA (reatapharma.com) - Net earnings per share (EPS TTM)